Sacral Nerve Stimulation For Urinary Incontinence — NCD 249 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 249 governing sacral nerve stimulation for urinary incontinence, effective January 9, 2026. Here's what billing teams need to do.

The CMS sacral nerve stimulation coverage policy under NCD 249 Medicare has four hard coverage criteria — and every one of them is a claim denial waiting to happen if your documentation doesn't hold up. This policy covers sacral nerve stimulation for urinary urge incontinence, urgency-frequency syndrome, and urinary retention. The policy does not list specific CPT or HCPCS codes, so your billing team needs to verify correct code assignment against current Medicare billing guidelines and MAC-level guidance.

---

Quick-Reference Table

Field	Detail Copy
Payer	CMS (Centers for Medicare & Medicaid Services)
Policy	Sacral Nerve Stimulation For Urinary Incontinence
Policy Code	NCD 249
Change Type	Modified
Effective Date	2026-01-09
Impact Level	High
Specialties Affected	Urology, Urogynecology, Neurology, General Surgery
Key Action	Audit documentation for all four medical necessity criteria before billing the permanent implant

---

CMS Sacral Nerve Stimulation Coverage Criteria and Medical Necessity Requirements 2026

The CMS sacral nerve stimulation coverage policy draws a clear line: coverage is available, but only after patients have cleared a documented gauntlet of prior treatment failure and procedural success.

Coverage applies to three indications: urinary urge incontinence, urgency-frequency syndrome, and urinary retention. All three are covered under NCD 249 Medicare as of the original effective date of January 1, 2002. The January 9, 2026 modification keeps those indications intact — the fight is in the criteria, not the diagnosis list.

Four conditions must be met for any of the three indications. Miss one, and you're looking at a claim denial. Here they are straight from the policy:

First: The patient must be refractory to conventional therapy. That means documented failure of behavioral therapy, pharmacologic therapy, and/or surgical corrective therapy. "Documented" is doing real work here. Vague chart notes don't satisfy this. You need a clear record showing what was tried, when, and why it failed.

Second: The patient must be an appropriate surgical candidate. Specifically, implantation under anesthesia must be feasible. This isn't a checkbox — your medical director and the operating physician need to support this in the record. If there's any question about surgical candidacy, that question needs an answer in the documentation before the claim goes out.

Third: The patient must complete a successful test stimulation. This is the gate before permanent implantation. A patient cannot go straight to the permanent implant. The test phase must happen first, and it must show a 50% or greater improvement. Improvement is measured through voiding diaries — not clinical observation, not physician attestation, but patient-recorded voiding diaries. If the diary data isn't in the chart, you don't have proof of success.

Fourth: The patient must be able to record voiding diary data. This sounds simple. It isn't. Patients who can't reliably keep voiding diaries — due to cognitive impairment, caregiver gaps, or other barriers — may not meet this criterion. That decision needs to be in the record before you bill the permanent implant.

The real issue here is documentation sequencing. The test stimulation and the permanent implant are two separate covered services under NCD 249. Both are billable — but the permanent implant claim lives or dies on whether the test phase was documented correctly first.

CMS doesn't specify prior authorization requirements in NCD 249 itself. But your Medicare Administrative Contractor may have local coverage determination policies that add prior authorization or additional documentation requirements on top of the NCD. Check with your MAC before assuming NCD 249 alone is sufficient.

---

CMS Sacral Nerve Stimulation Exclusions and Non-Covered Indications

The policy is specific about who is excluded, and this is where many denials originate.

Three patient populations are explicitly excluded — even if they present with urge incontinence, urgency-frequency syndrome, or urinary retention:

Stress incontinence. If the primary diagnosis is stress incontinence, sacral nerve stimulation is not covered. This matters because mixed incontinence presentations are common. If stress incontinence is a component of the clinical picture, you need the record to clearly establish that urge incontinence or urgency-frequency syndrome is the primary indication.

Urinary obstruction. Patients with urinary obstruction are excluded. The obstruction needs to be addressed first — or ruled out — before sacral nerve stimulation billing is supportable.

Specific neurologic diseases. The policy calls out diabetes with peripheral nerve involvement as the example. The broader exclusion covers neurologic diseases associated with secondary manifestations of the three covered indications. This is the ambiguous one. "Specific neurologic diseases" is not exhaustively defined in the policy text. If your patient population includes diabetics with neuropathy or other peripheral nerve conditions, loop in your compliance officer before billing. This is an area where a MAC's local coverage determination may provide more specific guidance.

The exclusion language is intentionally broad on the neurologic front. CMS is signaling that sacral nerve stimulation isn't appropriate when the underlying mechanism is neurologic rather than idiopathic. But the line between "neurologic" and "not neurologic" isn't always clean in clinical practice. If you're unsure whether a specific patient's neurology exclusion applies, get a compliance review before the claim goes out.

---

Coverage Indications at a Glance

---

CMS Sacral Nerve Stimulation Billing Guidelines and Action Items 2026

This is where the documentation requirements translate into billing risk. The sacral nerve stimulation billing process has two stages — test and permanent — and documentation failure at stage one kills reimbursement at stage two.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Sacral Nerve Stimulation Under NCD 249

A Note on Code Availability

The NCD 249 policy document does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for older NCDs — the coverage determination was originally established in 2002, before standardized code tables were routinely embedded in NCD text.

This means your billing team carries more responsibility for correct code identification. You cannot pull codes directly from the NCD text. Instead:

• Reference your MAC's LCD for sacral nerve stimulation — this is where procedure-specific codes are most likely documented at the regional level
• Cross-reference current CPT coding guidelines for sacral nerve stimulation implant procedures
• Verify ICD-10-CM diagnosis codes for urinary urge incontinence, urgency-frequency syndrome, and urinary retention with your coding team

Billing the wrong code — or billing a covered service under a code your MAC doesn't recognize for this indication — produces a claim denial that the NCD itself won't protect you from. Get the code list from your MAC directly.

The claims processing instructions in NCD 249 reference several transmittals: AB-03-028, A-02-020, AB-01-166, AB-01-143, and Transmittal 125 (Medicare Claims Processing). These are older transmittals from the early 2000s and may not reflect current coding. Use them as historical context, not as your current billing reference.

---